Press Releases

Worldwide, approximately 260 million people suffer from chronic hepatitis B which is currently incurable. However, there is now a shimmer of hope on the horizon as scientists at the DZIF have

The global increase of tuberculosis patients is alarming, particularly the increase of cases of so-called multidrug-resistant tuberculosis (MDR-TB) in which the pathogen is insensitive to the most

Pseudomonas aeruginosa bacteria are hospital germs and are often resistant to common antibiotics. They can infect all human organs and implants, and can persist in the body for long periods of time in

Globally, Brazil has been the hardest hit by the current Zika outbreak. Almost all cases of Zika-associated malformations in newborns have been reported from this country. DZIF scientists from the

Scientists at the Institute of Tropical Medicine of the University of Tübingen, the German Center for Infection Research (DZIF), and of Sanaria Inc. have developed an infection system that allows

Tsutsugamushi fever, or “scrub typhus”, is an infectious disease related to typhus, which is endemic in large parts of Asia. The disease has an estimated incidence of approximately one million cases

The first joint study to be conducted across all twelve clinical trial units at the German Center for Infection Research (DZIF) has been initiated. The aim of the study is to improve vaccine

An artificially produced inhibitor curbs Ebola virus replication and could be used to develop drugs for life-threatening Ebola virus epidemics. An European team of scientists bases this hope on

The National Reference Center at the Research Center Borstel has confirmed a Europe-wide outbreak of a multidrug-resistant Mycobacterium tuberculosis strain in 29 refugees from the Horn of Africa. The

An international tuberculosis consortium—including the Research Center Borstel—has succeeded in developing a standardised and internationally recognised method that is able to better predict in